Cover Image
市場調查報告書

菲律賓的醫藥品、醫療產業分析

Philippines Pharmaceuticals and Healthcare Report Q2 2017

出版商 BMI Research 商品編碼 177615
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
菲律賓的醫藥品、醫療產業分析 Philippines Pharmaceuticals and Healthcare Report Q2 2017
出版日期: 2017年03月08日 內容資訊: 英文 100 Pages
簡介

本報告提供菲律賓的製藥、醫療產業結構和最新趨勢相關分析,今後10年的產業規模的動向估計,產業的課題 (風險) 和未來商機 (利潤) 相關評估,政府的政策、規定,競爭環境,主要企業簡介等資訊彙整,為您概述為以下內容。

BMI的見解

SWOT分析

產業預測

  • 醫藥品市場預測
  • 醫療市場預測
  • 處方藥市場預測
  • 專利藥市場預測
  • 學名藥市場預測
  • 一般用醫藥品 (成藥) 市場預測
  • 醫藥品貿易的預測

產業的風險/利潤、等級

  • 亞太地區:風險/利潤、等級
  • 菲律賓:風險/利潤、等級
    • 利潤
    • 風險

法規

  • 知識產權問題
  • 價格設定的體制
  • 醫療費償付的體制

市場概況

  • 醫療部門
  • 醫療保險
  • 臨床實驗
  • 流行病學

競爭環境

  • 研究開發意向型產業
  • 學名藥品廠商
  • 醫藥品的流通
  • 醫藥品的零售部門

企業簡介

人口結構的預測

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關注記
  • 風險/利潤、等級技術

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1748-376X

BMI View: Generic drugmakers will be the primary beneficiaries of the Philippine government's investment into healthcare. While the expansion of universal healthcare is a positive for the broader pharmaceutical sector, the specific target of President Rodrigo Duterte's 2017 budget and other public health initiatives is expanding healthcare access to low-income Filipinos. This will grow a patient segment that, given constraints on affordability, will demand low-cost pharmaceuticals. Such opportunities will spur greater investment from both multinational drugmakers with strong generic portfolios and Indian pharmaceutical firms, intensifying the level of competition.

Headline Expenditure Projections

  • Pharmaceuticals: PHP156.2bn (USD3.38bn) in 2016, rising to PHP162.3bn (USD3.28bn) in 2017; +3.9% in local currency terms and -3.0% in US dollar terms.
  • Healthcare: PHP722.3bn (USD15.63bn) in 2016, rising to PHP794.0bn (USD16.04bn) in 2017; +9.9% in local currency terms and +2.6% in US dollar terms.

Table of Contents

BMI Industry View

  • Table: Headline Pharmaceuticals & Healthcare Forecasts (Philippines 2015-2021)

SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2013-2021)
  • Healthcare Market Forecast
    • Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2013-2021)
    • Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2013-2021)
    • Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2013-2021)
  • Prescription Drug Market Forecast
    • Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2013-2021)
  • Patented Drug Market Forecast
    • Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2013-2021)
  • Generic Drug Market Forecast
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2013-2021)
  • OTC Medicine Market Forecast
    • Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2013-2021)
  • Pharmaceutical Trade Forecast
    • Table: Pharmaceutical Trade Data And Forecasts (Philippines 2015-2021)
    • Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2015-2021)

Industry Risk/Reward Index

  • Asia Pacific Risk/Reward Index - Q2 2017
  • Philippines Risk/Reward Index
    • Rewards
    • Risks

Regulatory Review

  • Intellectual Property Issues
  • Pricing Regime
  • Reimbursement Regime

Market Overview

  • Healthcare Sector
    • Table: Healthcare Resources (Philippines 2011-2016)
    • Table: Healthcare Personnel (Philippines 2011-2016)
    • Table: Healthcare Activity (Philippines 2011-2016)
  • Health Insurance
  • Clinical Trials
  • Epidemiology

Competitive Landscape

  • Research-Based Industry
    • Table: Multinational Market Activity
  • Generic Drugmakers
  • Pharmaceutical Distribution
  • Pharmaceutical Retail Sector
    • Table: Overview Of BnB, BNB and P100 Programme
    • Table: Cost Of Generic Drugs In Philippines (PHP)
    • Table: Number Of BnBs And BNBs In Selected Philippine Regions

Company Profile

  • GlaxoSmithKline Philippines
  • Novartis

Demographic Forecast

  • Table: Population Headline Indicators (Philippines 1990-2025)
  • Table: Key Population Ratios (Philippines 1990-2025)
  • Table: Urban/Rural Population & Life Expectancy (Philippines 1990-2025)
  • Table: Population By Age Group (Philippines 1990-2025)
  • Table: Population By Age Group % (Philippines 1990-2025)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top